In vivo therapeutic synergy of SAR650984, a humanized anti-CD38 antibody, in combination with melphalan in a multiple myeloma xenograft.

被引：0
|
作者：
Lejeune, Pascale
Blanc, Veronique
Courta, Jacqueline
Egile, Coumaran
Vrignaud, Patricia
Deckert, Jutta
Park, Peter
Bissery, Marie-Christine
机构：
[1] Sanofi Aventis, Vitry Sur Seine, France
[2] ImmunoGen Inc, Waltham, MA USA
来源：
CANCER RESEARCH | 2009年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2797
引用
收藏
页数：1
相关论文
共 50 条
  • [1] SAR650984, A HUMANIZED ANTI-CD38 ANTIBODY, POTENTLY TARGETS CANCER CELLS THROUGH MULTIPLE MECHANISMS
    Cai, T.
    Zhang, B.
    Yang, G.
    Song, Z.
    Dai, S.
    He, T.
    Simard, D.
    Licht, S.
    Adrian, F.
    Cheng, H.
    Corzo, K.
    HAEMATOLOGICA, 2014, 99 : 355 - 355
  • [2] SAR650984, an anti-CD38 antibody, shows anti-tumor activity in a preclinical model of multiple myeloma.
    Hann, Byron
    Cai, T. I.
    Wang, Donghui
    Hom, Yun-Kit
    Aftab, Blake T.
    Martin, Tom
    Wolf, Jeffrey
    CANCER RESEARCH, 2013, 73 (08)
  • [3] SAR650984: Characterization of a potent phase I humanized anti-CD38 antibody for the treatment of multiple myeloma and other hematologic malignancies.
    Wetzel, Marie-Cecile
    Nicolazzi, Celine
    Vallee, Francois
    Deckert, Jutta
    Dumontet, Charles
    Plesa, Adriana
    Kannt, Aimo
    Mikol, Vincent
    Chiron, Marielle
    Vincent, Loic
    Blanc, Veronique
    CANCER RESEARCH, 2013, 73 (08)
  • [4] Broad spectrum of antitumor activity of SAR650984, a humanized anti-CD38 antibody targeting hematological malignancies
    Lejeune, Pascale
    Deckert, Jutta
    Mayo, Michele
    Whiteman, Kathy
    Johnson, Starrla
    Guyre, Cheryl
    Blanc, Veronique
    Park, Peter
    Lutz, Robert
    Bissery, Marie-Christine
    Vrignaud, Patricia
    CANCER RESEARCH, 2009, 69
  • [5] SAR650984, a humanized anti-CD38 antibody potently modulates intracellular and extracellular nucleotide levels of cancer cells
    Zhang, Bailin
    Yang, Guang
    Dai, Shujia
    He, Tim
    Simard, Daniel
    Song, Zhili
    Licht, Stuart
    Adrian, Francisco
    Cheng, Hong
    Cai, Ti
    CANCER RESEARCH, 2014, 74 (19)
  • [6] SAR 650984, a Therapeutic Anti-CD38 Monoclonal Antibody, Blocks CD38-CD31 Interaction in Multiple Myeloma
    An, Gang
    Jiang, Hua
    Acharya, Chirag
    Zhong, Mike Y.
    Cai, Ti
    Yang, Guang
    Song, Zhili
    Theilhaber, Joachim
    Adrian, Francisco
    Tai, Yu-Tzu
    Anderson, Kenneth C.
    BLOOD, 2014, 124 (21)
  • [7] KIR and HLA Genotypes Influence Clinical Outcome in Multiple Myeloma Patients Treated with SAR650984 (Anti-CD38) in Combination with Lenalidomide and Dexamethasone
    Marra, John
    Du, Juan
    Hwang, Jimmy
    Wolf, Jeffrey L.
    Martin, Thomas G.
    Venstrom, Jeffrey M.
    BLOOD, 2014, 124 (21)
  • [8] All-trans retinoic acid enhances the effector functions of the anti-CD38 antibody SAR650984
    Bush, Lucas
    Harper, David
    Greco, Rita
    Song, Zhili
    Yang, Guang
    Adrian, Francisco
    CANCER RESEARCH, 2015, 75
  • [9] SAR650984, a humanized anti-CD38 antibody, shows potent in vitro activity by multiple mechanisms against various hematologic tumor cell lines.
    Deckert, Jutta
    Yi, Yong
    Chicklas, Sharon
    Mayo, Michele
    Chittenden, Thomas
    Park, Peter
    CANCER RESEARCH, 2009, 69
  • [10] A PHASE I TRIAL OF SAR650984, A CD38 MONOCLONAL ANTIBODY, IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA
    Martin, T.
    Strickland, S.
    Glen, M.
    Maikhael, J.
    Charpentier, E.
    Hsu, K.
    HAEMATOLOGICA, 2014, 99 : 519 - 519
12345